MERCURY-3: a randomized comparison of netarsudil/latanoprost and bimatoprost/timolol in open-angle glaucoma and ocular hypertension
Ingeborg Stalmans(Universitair Ziekenhuis Leuven), Gábor Holló(Buda Health Center), Bogomil Voykov(STZ eyetrial), Tomasz Żarnowski(Medical University of Lublin), Guna Laganovska(Pauls Stradiņš Clinical University Hospital), Marek Fichtl(Charles University), Cédric Schweitzer(Université de Bordeaux), Francesco Oddone(Fondazione G.B. Bietti), José I. Belda(Hospital Quirón Torrevieja), Kin Sheng Lim(St Thomas' Hospital), Anton Hommer
Graefe s Archive for Clinical and Experimental Ophthalmology
August 24, 2023
Cited by 22
Related Papers
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
|Nature Medicine|2001|1.7k
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up
|Ophthalmology|2018|320
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up
|Ophthalmology|2019|252
A Schlemm Canal Microstent for Intraocular Pressure Reduction in Primary Open-Angle Glaucoma and Cataract
|Ophthalmology|2018|222
Mechanism of Action of Bimatoprost, Latanoprost, and Travoprost in Healthy Subjects
|Ophthalmology|2008|167